Economy/Home · Economy

HLB Group Shares Show Divergent Moves on the 17th... HLB Innovation Surges Over 8% vs. HLB Therapeutics Plunges Over 14%

On the afternoon of the 17th, HLB group shares are showing clearly divergent movements. While some affiliates are on the rise, others are posting double-digit declines, making differentiation among the group's stocks increasingly pronounced. As of 1:13 p.m. on the 17th, HLB (028300) is trading at 2

Oseong Kwon
Staff Reporter
3 min read
HLB Group Shares Show Divergent Moves on the 17th... HLB Innovation Surges Over 8% vs. HLB Therapeutics Plunges Over 14%
CBC News

On the afternoon of the 17th, HLB group shares are showing clearly divergent movements. While some affiliates are on the rise, others are posting double-digit declines, making differentiation among the group's stocks increasingly pronounced.

As of 1:13 p.m. on the 17th, HLB (028300) is trading at 28,600 won, up 1.77% from the previous trading day. HLB Pharmaceutical (047920) is also in positive territory, rising 1.47% to 6,900 won. In particular, HLB Innovation (024850) is trading up 8.58% at 13,410 won, posting the most notable gain among the group's stocks. HLB Panagen (046210) is also trading 0.20% higher at 1,002 won.

Meanwhile, decliners are also notable. HLB Therapeutics (115450) is recording the largest drop among the group's stocks, plunging 14.37% to 1,400 won. HLB Biostep (278650) is also trading down 1.85% at 3,440 won, continuing its weakness.

Some stocks are unchanged. HLB LifeScience (067630) and HLB Global (003580) are maintaining flat levels at 2,345 won and 1,374 won, respectively, both with a 0.00% change.

As such, HLB group shares on this day show a mix of gains, losses, and flat performance. In particular, HLB Innovation's rise of over 8% stands in sharp contrast to HLB Therapeutics' fall of over 14%, highlighting clear price differentiation among the group's stocks.

[※ This article is for investment reference purposes only, and investment decisions and any resulting responsibility rest with the investor.]

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.